Trial intelligence / Profile preview

Skin disinfection with octenidine dihydrochloride for prevention of catheter-associated infections

DRKS00000006Phase 4Completed

Sponsor
Universitätsklinikum Freiburg
Start
Aug 2008
Modality
Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
2
01

Overview

A Phase 4 trial of octenidine in catheter-associated urinary tract infection (CAUTI), Bacteremia, sepsis, sponsored by Universitätsklinikum Freiburg. Started Aug 2008; status: completed.

02

Drugs

octenidine
03

Conditions

catheter-associated urinary tract infection (CAUTI)Bacteremiasepsis

Beyond the preview

Go deeper on DRKS00000006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00000006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call